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Abstract 15 
The replacement of fish oil (FO) with a DHA-rich Schizochytrium sp. algal meal 16 
(AM) at two inclusion levels (11% and 5.5% of diet) was tested in Atlantic salmon 17 
post-smolts compared to fish fed a FO diet of northern (NFO) or southern hemisphere 18 
(SFO) origin. Fish were preconditioned prior to the 19-week experimental feeding 19 
period to reduce long-chain polyunsaturated fatty acid (LC-PUFA) and persistent 20 
organic pollutant levels (POPs). Dietary POP levels differed significantly between 21 
treatments in the order of NFO>SFO>11AM/5.5AM and were subsequently reflected 22 
in the flesh. Fish fed the 11AM diet contained similar DHA levels (g.100g
-1
 flesh) to 23 
FO-fed fish, despite percentage differences. However, the low levels of EPA in the 24 
diets and flesh of algal-fed fish compromised the overall nutritional value to the final 25 
consumer. Nevertheless, further developments in microalgae culture offer a 26 
promising alternative lipid source of LC-PUFA to FO in salmon feeds that warrants 27 
further investigation. 28 
 29 
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1. Introduction 37 
It is widely accepted that fish consumption is an excellent source of the 38 
beneficial omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA), 39 
eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3), 40 
which have important roles in protecting against cardiovascular disease as well as 41 
neurological and inflammatory conditions among other health benefits (Calder & 42 
Yaqoob, 2009). Nevertheless, fish consumption, particularly oily fish, is also a major 43 
dietary exposure route for humans to persistent organic pollutants (POPs), including 44 
dioxins [polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated 45 
dibenzofurans (PCDFs)], dioxin-like polychlorinated biphenyls (DL-PCBs) and 46 
polybrominated diphenyl ethers (PBDEs). These lipophilic compounds are easily 47 
absorbed and rapidly distributed to lipid-rich organs and tissues which can result in 48 
their bioaccumulation. Consequently, the beneficial effects may be offset by the 49 
negative risks associated with fish intake. 50 
In farmed fish, such as Atlantic salmon (Salmo salar), the traditional marine-51 
derived components of fish feed, fish oil and fish meal, are considered to be the major 52 
sources of POPs (Berntssen, Julshamn & Lundebye, 2010a; Jacobs, Covaci & 53 
Schepens, 2002). Reducing the POP levels in fish oils, and ultimately the feeds and 54 
flesh of fish, without affecting the LC-PUFA content, has been achieved using 55 
decontamination techniques (Berntssen et al., 2010b; Sprague et al., 2010) or by 56 
utilising less polluted fish oils from the southern hemisphere (Sprague et al., 2010). 57 
However, the increased competition from the pharmaceutical and nutraceutical 58 
industries for n-3 LC-PUFA coupled with the stagnated global supply of wild catch 59 
fisheries has led to increased prices and supply pressures resulting in the aquafeed 60 
sector investigating alternative lipid sources.     61 
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The partial and complete replacement of marine ingredients with agricultural 62 
plant products, mainly of oilseed origin, has been performed in salmon without any 63 
detrimental effects on growth performance or fish health (e.g. Bell, Henderson, 64 
Tocher & Sargent, 2004; Bell, McGhee, Dick & Tocher, 2005). Such substitution 65 
reduces the levels of undesirable POPs (Bell et al., 2005; Bell, Dick, Strachan, Guy, 66 
Berntssen & Sprague, 2012; Berntssen et al., 2010a). Conversely, since the fatty acid 67 
composition of fish tissue reflects that of the diet (Sargent, Tocher and Bell, 2002), 68 
increasing the vegetable content in aquafeeds reduces the favourable LC-PUFA levels 69 
abundant in fish oils, thereby compromising the overall nutritional quality of the final 70 
product. Finishing diets can be employed to restore flesh n-3 LC-PUFA levels in 71 
vegetable fed fish, although this still relies upon the inclusion of fish oils (Bell et al., 72 
2004; 2012), albeit at the risk of increasing POP levels in a previously low 73 
contaminated product (Bell et al., 2005, 2012). Since marine fish lack the conversion 74 
pathways to efficiently produce EPA and DHA at appreciable levels, these essential 75 
fatty acids must be obtained through the diet (Sargent et al., 2002). 76 
Marine microalgae are primary producers of n-3 LC-PUFA, and are therefore a 77 
promising alternative to the traditional marine derived ingredients of fish feed. 78 
Several species have been identified as potential sources, among which the 79 
thraustochytrids have been preferred due to their ease for large-scale heterotrophic 80 
cultivation under controlled conditions to produce a high lipid product rich in n-3 LC-81 
PUFA (Lewis, Nichols & McMeekin, 1999; Ratledge, 2005). Furthermore, unlike 82 
crude oils and oilseeds, algal biomass produced by fermentation is generally free 83 
from environmental contaminants and heavy metals (Ratledge, 2005). Schizochytrium 84 
sp. is a fast growing thraustochytrid microalgae, rich in DHA, with a relatively simple 85 
culture process compared to other single-cell microalgae (Ganuza, Benítez-Santana, 86 
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Atalah, Vega-Orellana, Ganga & Izquierdo, 2008; Lewis et al. 1999). Subsequently, 87 
the aquaculture industry has investigated the potential of thraustochytrids, particularly 88 
Schizochytrium sp. in either dried biomass or oil extracted form, as an alternative 89 
lipid source in enriching zooplankton for feeding to finfish larvae (Barclay & Zeller, 90 
1996), supplementing channel catfish diets, Ictalurus punctatus, (Li, Robinson, 91 
Tucker, Manning & Khoo, 2009), or as replacement for fish oils in diets for sea 92 
bream, Sparus aurata (Ganuza et al., 2008), and Atlantic salmon (Carter, Bransden, 93 
Lewis & Nichols, 2003; Miller, Nichols & Carter, 2007). However, to date no such 94 
studies have been performed in post-smolt salmon to assess Schizochytrium sp. 95 
inclusion as a potential replacement for fish oil in grow-out feeds and its effects on 96 
the nutritional quality of the final product. 97 
The present study therefore evaluated the replacement of fish oil with a DHA-98 
rich algal meal, derived from Schizochytrium sp., at two different inclusion levels (11 99 
and 5.5% of diet) on the fatty acid and POP compositions of Atlantic salmon diets 100 
and flesh compared to fish fed a fish oil diet of either northern or southern 101 
hemisphere origin. 102 
 103 
2. Materials and Methods 104 
2.1. Experimental set-up and diets 105 
The trial was performed at Marine Harvest’s (Scotland) Feed Trial Unit (Ardnish, 106 
Inverness-shire, Scotland) using a commercial strain of 1,700 1+ Atlantic salmon 107 
post-smolts. Fish (850 ± 100 g, mean ± SD) were initially stocked into four 125 m
3
 108 
sea pens and acclimatized for 10 weeks during which they were fed a high 109 
rapeseed/fish oil (6:1, w/w) preconditioning diet in order to reduce flesh POPs and 110 
LC-PUFA levels. Fish (1534 ± 400 g) were then split between twelve pens (130 fish 111 
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per pen) and acclimated for one-week prior to the enrichment phase. Triplicate pens 112 
were fed one of four diets for 19 weeks consisting of either (a) northern hemisphere 113 
fish oil (NFO) as control, (b) southern hemisphere fish oil (SFO), or (c/d) a DHA-rich 114 
drum dried Schizochytrium sp. algal meal (AquaGrow Gold
®
; Advanced 115 
BioNutrition, Columbia, MD, USA) at two dietary inclusion levels, 5.5% (5.5AM) or 116 
11% (11AM) with 25% and 21% added rapeseed oil respectively. All diets were 117 
formulated (Table 1) and produced by BioMar UK (Grangemouth, Scotland). Fish 118 
were fed twice daily using automatic feeders with uneaten food collected via waste 119 
uplift systems to monitor feed intake. Feed fed, waste feed and the resulting net feed 120 
intake were registered daily, as were any mortalities. Fish were reared under natural 121 
photoperiod and temperature (range 6.5-13.8
o
C) for the duration of the trial. At the 122 
start and end of the enrichment phase, all fish in each pen were bulk weighed. The 123 
specific growth rate (SGR) was calculated as: SGR (%bw.day
-1
) = 124 
100[ln(WF/WI)/d], where WF and WI are the final and initial weights (g) 125 
respectively, and d is the number of days. Thermal growth coefficient (TGC) was 126 
calculated as TGC = (WF
1/3
-WI
1/3
)  (1000/DD), where WF and WI are as previously 127 
addressed for SGR, and DD is the cumulative daily water temperature (
o
C) in SW. 128 
 129 
2.2. Sample collection 130 
Samples of the precondition and experimental feeds were collected, wrapped in 131 
aluminium foil, before placing into sealable polythene bags and stored at -70
o
C until 132 
analysis. Diets were analysed using standard methods to determine crude lipid (acid 133 
hydrolysis of soxhlet samples, Teactor Soxtec method); moisture (AOAC, 2000); 134 
crude protein (Kjeldahl, calculated as N6.25); Ash (AOAC, 2000) and energy 135 
(bomb calorimeter: Gallenkamp Autobomb, calibrated with benzoic acid). 136 
 7 
At the end of the preconditioning phase (initial), 4 fish were removed from the 137 
cages, anaesthetized and killed by a single blow to the head. Flesh from the 138 
Norwegian Quality Cut (NQC) region was removed, wrapped in aluminium foil and 139 
stored in sealable polythene bags at -70
o
C until analysis. Following termination of the 140 
enrichment phase, 6 fish per dietary treatment were anaesthetized and killed by a 141 
single blow to the head and NQC flesh removed and stored as per initial fish. Fatty 142 
acid analysis was performed for individual fish, whereas flesh was pooled from each 143 
pen (2 initial, 3 per enrichment treatment) for POPs analysis. The experiment was 144 
subjected to ethical approval by the University of Stirling Ethics Committee and 145 
carried out in accordance with the UK Animals (Scientific Procedures) Act 1986.     146 
 147 
2.3. Lipid content and total lipid fatty acid composition 148 
Total lipid content was determined gravimetrically after extraction of ~1 g tissue 149 
or diet by homogenizing in 20 or 36 volumes of ice-cold chloroform/methanol (2:1 150 
v/v) respectively, using an Ultra-Turrax tissue disrupter (Fisher Scientific, 151 
Loughborough, UK) according to Folch, Lees and Stanley (1957). Non-lipid 152 
impurities were isolated by washing with 0.88% (w/v) KCl and the upper aqueous 153 
layer removed by aspiration and the lower solvent layer containing the lipid extract 154 
dried under oxygen-free nitrogen. 155 
Fatty acid methyl esters (FAMEs) from total lipid were prepared by acid-156 
catalyzed transmethylation at 50
o
C for 16h (Christie, 1993). FAME were extracted 157 
and purified as described previously (Tocher & Harvie, 1988) and separated and 158 
quantified by GC using a Fisons GC-8160 (Thermo Scientific, Milan, Italy) equipped 159 
with a 30 m x 0.32 mm i.d. x 0.25 µm ZB-wax column (Phenomenex, Cheshire, UK), 160 
‘on column’ injection and flame ionization detection. Hydrogen was used as carrier 161 
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gas with initial oven thermal gradient from 50 to 150
o
C at 40
o
C.min
-1
 to a final 162 
temperature of 230
o
C at 2
o
C.min
-1
. Individual FAME were identified by comparison 163 
to known standards (Supelco™ 37-FAME mix; Sigma-Aldrich Ltd., Poole, UK) and 164 
published data (Tocher & Harvie, 1988). Data were collected and processed using 165 
Chromcard for Windows (Version 1.19; Thermoquest Italia S.p.A., Milan, Italy). 166 
Fatty acid content per g of tissue was calculated using heptadecanoic acid (17:0) as 167 
internal standard.   168 
 169 
2.4. Persistent organic pollution (POP) extraction and clean-up  170 
The 29 PCDD/F and DL-PCB congeners with WHO-TEF values (Van den Berg 171 
et al., 2006) and nine PBDE congeners (IUPAC numbers 28, 47, 49, 66, 99, 100, 153, 172 
154, 183) were targeted in samples as previously described (Sprague, Dick, Medina, 173 
Tocher, Bell & Mourente, 2012). Briefly, lipid was extracted from 25 g of diet or 174 
freeze-dried tissue (ca. 65 g wet weight) by accelerated solvent extraction 175 
(ASE™100; Dionex, Camberley, UK) following addition of 5 ng.ml-1 PBDE119 and 176 
2 ng.ml
-1
 
13
C-labelled PCDD/F and PCB internal standards (Wellington Laboratories, 177 
Guelph, Ontario, Canada). Sample extracts were loaded for further clean-up and 178 
fractionation of analytes using the automated Power-Prep™ system (Fluid 179 
Management Systems Inc., Watertown, MA, USA) followed by conditioning of the 180 
disposable column series, consisting of multi-layered silica (4 g acid, 2 g base, 1.5 g 181 
neutral), basic alumina (8 g) and carbon (2 g). Total run time was 150 min followed 182 
by a 40 min decontamination programme. The mono-ortho PCB and PBDE fraction 183 
(F1) was eluted in 120 ml isohexane/dichloromethane (1:1, v/v) and the PCDD/F and 184 
non-ortho PCB fraction (F2) in 120 ml toluene. Fractions underwent further clean up 185 
with F1 transferred to silanized vials containing 150 µl nonane as keeper and 186 
 9 
evaporated to 500 or 100 µl prior to analysis for PBDE and mono-ortho PCBs, 187 
respectively, and F2 transferred to conical GC autosampler vials containing 10 µl of 188 
nonane as keeper and evaporated to 50 or 10 µl prior to analysis for non-ortho PCB 189 
and PCDD/F, respectively. 190 
 191 
2.5. Instrumental analysis 192 
Mono-, non-ortho PCBs and PCDD/Fs extracts were analysed using a PolarisQ 193 
ion trap MS/MS coupled to a Trace GC 2000 (Thermo Finnigan, Bremen, Germany) 194 
equipped with a 30 m x 0.25 mm i.d. x 0.25 µm Rxi
®
-5ms (5% diphenyl, 95% 195 
dimethyl polysiloxane) fused-silica capillary column (Thames Restek Ltd., 196 
Saunderton, UK). Samples and standards (2 µl) were injected in splitless mode. The 197 
GC oven temperature programmes were as reported by Sprague et al. (2012). Helium 198 
was used as carrier gas at constant flow (0.8 ml.min
-1
). Injector, transfer line and ion 199 
source temperatures were maintained at 250, 305 and 250
o
C, respectively. The MS 200 
operated in positive electron ionisation (EI+) mode using automatic gain control with 201 
electron energy of 70 eV and emission current of 250 µA. Quantification was based 202 
on US Environmental Protection Agency isotopic dilution methods (EPA, 1994, 203 
1999). Relative response factors (RRFs) for individual 2,3,7,8-chlorosubstituted 204 
PCDD/F and DL-PCB congeners were determined using calibration standards. 205 
Xcalibar version 1.3 was used for data acquisition and results processing. 206 
PBDEs (1µl) were injected in splitless mode (225
o
C, 1.5 min) with surge (240 207 
kPa) on a Trace GC Ultra equipped with a 30 m x 0.25 mm i.d. x 0.25 m ZB5-MS 208 
column (Phenomenex, Cheshire, UK) coupled to a Trace DSQ MS (Thermo 209 
Finnigan, Bremen, Germany) operating in negative chemical ion mode (CI
-
). The GC 210 
temperature programme was as previously reported (Sprague et al., 2012). Helium 211 
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was used as carrier gas at constant flow (1.2 ml.min
-1
) and methane as reagent gas 212 
(2.0 ml.min
-1
). The MS operated in selective ion monitoring (SIM) mode by 213 
monitoring bromide isotope ions (m/z 81 and 79) with dwell time of 80 ms. 214 
Quantification of PBDE congeners was performed by congener-specific linear 215 
calibration curves (r
2
 >0.99). Xcalibar version 1.4 was used for data acquisition and 216 
results processing. 217 
 218 
2.6. Quality assurance (QA) and quality control (QC) 219 
Samples were ran with a procedural blank, a duplicate sample and an ‘in-house’ 220 
reference material, consisting of pooled salmon flesh, cross referenced with an 221 
external laboratory. Limits of detection (LOD) were determined using a software 222 
option for estimating signal-to-noise (S/N) ratio, where limit of quantification (LOQ) 223 
was three times LOD (nine times S/N ratio). LOQs were in the range of 0.01-0.03 224 
pg.g
-1
 wet weight (ww) for PCDD/Fs, 0.1-0.5 pg.g
-1
 ww for non-ortho PCBs, 2.1-3.9 225 
pg.g
-1
 ww for mono-ortho PCBs and 6-48 pg.g
-1
 ww for PBDEs. Recovery values for 226 
PCDD/Fs and DL-PCBs, based on congener-specific response factors of 
13
C internal 227 
surrogate standard relative to 
13
C performance standards (EPA, 1994), were in the 228 
range of 76-114%. Percentage recoveries for PBDEs, based on spiked sample matrix 229 
with internal standards for all congeners, were in the range of 78-118%. Method 230 
performance was further assessed through satisfactory participation of 231 
‘Interlaboratory Comparison on Dioxins in Food’ tests organized by the Norwegian 232 
Institute for Public Health. Results for PCDD/Fs and DL-PCBs are presented on a 233 
WHO-TEQ basis using 2006 TEFs (Van den Berg et al., 2006), although total 234 
PCDD/Fs and DL-PCB values are also expressed on 1998 TEFs (Van den Berg et al., 235 
1998) for comparative purposes.  236 
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 237 
2.7. Statistical analysis  238 
Results are presented as mean and relative standard deviation (%RSD), unless 239 
otherwise specified. Statistical analyses were performed using Minitab
®
 v.16.1.0 240 
statistical software (Minitab Inc.). Data were assessed for normality with 241 
Kolmogorov-Smirnov test and for homogeneity of variances by Bartlett’s test and 242 
examination of residual plots and, where necessary, transformed using the natural 243 
logarithm or arcsine transformation. Data were compared by a one-way analysis of 244 
variance (ANOVA), with replicate cages nested within their dietary treatment groups. 245 
Post hoc comparisons were made using Tukey’s test (Zar, 1999). A significance of 246 
P<0.05 was applied to all statistical tests performed.  247 
 248 
3. Results and Discussion 249 
3.1. Dietary fatty acid and POP compositions 250 
The fatty acid compositions of the precondition and enrichment diets are 251 
presented in Table 1. Since the aim of the present study was to investigate the effects 252 
of the algal-feeds on LC-PUFA levels, fish were first fed a preconditioning feed 253 
consisting mainly of rapeseed oil to decrease n-3 LC-PUFA levels. Previous studies 254 
using vegetable-based diets have shown a decrease in the levels of flesh EPA and 255 
DHA due to the absence of these particular fatty acids in plant-based ingredients 256 
(Bell et al., 2004, 2005, 2012; Berntssen et al., 2010a). Thus, the precondition diet 257 
was largely comprised of oleic (18:1n-9), linoleic (18:2n-6), palmitic (16:0) and -258 
linolenic (18:3n-3) acids accounting for 46, 18, 8 and 7% of total fatty acids, 259 
respectively, with relatively low levels of EPA (3.6%) and DHA (2.3%) derived from 260 
the minor inclusion of fish oil and meal to maintain basic fish requirements.  261 
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Fatty acid compositions for both algal feeds were similar to the precondition diet 262 
due to the high inclusion of rapeseed oil. Commercial aquafeeds often incorporate 263 
blends of vegetable and fish or other oils to meet the nutritional requirements of the 264 
fish being farmed. Furthermore, the extraction of oil from the single cell biomass 265 
greatly increases the overall production costs (Miller et al., 2007; Ratledge, 2005), 266 
subsequently limiting its use as a sole oil source replacement for fish oil in feeds. 267 
Therefore, the present study combined the dried algal biomass with rapeseed oil to 268 
increase the essential n-3 LC-PUFA content resulting in a DHA content of 8.1% 269 
(11AM) and 5.3% (5.5AM). Additionally, the algal inclusion resulted in higher levels 270 
of the n-6 docosapentaenoic acid isomer (DPA; 22:5n-6) than the other feeds. This is 271 
a common feature of Schizochytrium sp. production, where approximately 20% of the 272 
DHA produced is DPA, a metabolically neutral fatty acid that has no overall effect on 273 
DHA uptake (Ratledge, 2005). Dietary lipid of the fish oil treatments, NFO and SFO, 274 
on the other hand contained 3-7 times lower levels of 18:1n-9, 18:2n-6 and 18:3n-3 275 
than the precon and algal diets. Both diets resembled the nutritional composition of 276 
their natural diets being largely characterized by 16:0, 18:1n-9, cetoleic (22:1n-11) 277 
and gondoic (20:1n-9) acids. The major PUFA were DHA and EPA with the NFO 278 
diet containing a lower EPA (8.0%) and a higher DHA (10.2%) level than the SFO 279 
diet (12.3 and 8.4%, respectively), as is commonly observed between oils sourced 280 
from the northern and southern hemispheres (Sargent et al., 2002).  281 
In addition to decreasing LC-PUFA levels, vegetable feeds have also been shown 282 
to contain lower POP levels than their fish oil counterparts (Bell et al., 2005, 2012; 283 
Berntssen et al., 2010a). Consequently, the vegetable-based precon diet contained 284 
lower POP levels (0.267 pgWHO-TEQ.g
-1 PCDD/Fs + DL-PCBs, 0.273 ng.g-1 ww 285 
PBDEs) than both fish oil based feeds, irrespective of origin (Table 2). Furthermore, 286 
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the SFO diet contained approximately half the level of POPs than the NFO diet 287 
(0.973 against 1.824 pgWHO-TEQ.g
-1 
ww PCDD/Fs + DL-PCBs and 1.086 against 288 
2.395 ng.g
-1
 ww PBDEs, respectively). Southern hemisphere fish oils typically 289 
contain lower POP levels than those from the northern hemisphere (Brevik et al., 290 
1990), reflecting the differences in pollution levels of marine waters between 291 
hemispheres (Fowler, 1990). The NFO control feed however, is in the range reported 292 
by Berntssen et al. (2010b) for a fish oil control diet, 2.31 against 2.18 pgWHO-293 
TEQ1998.g
-1
 ww PCDD/Fs + DL-PCBs reported in this study, and is lower than 294 
levels reported by Bell et al. (2005) for both a high- and low-fish oil diet (4.1 and 2.3 295 
pgWHO-TEQ1998.g
-1
 ww PCDD/Fs + DL-PCBs respectively). This highlights the 296 
awareness and efforts taken by the aquafeed industry in recent years in reducing 297 
dietary POP levels. Nevertheless, the lowest POP levels were measured in the two 298 
algal feeds (0.080 and 0.120 pgWHO-TEQ.g
-1 
ww PCDD/Fs + DL-PCBs and 0.154 299 
and 0.059 ng.g
-1
 ww PBDEs, 11AM and 5.5AM respectively) yielding a reduction 300 
of >94% compared to the NFO diet and >85% relative to SFO, similar to reductions 301 
seen where fish oil based feeds have been decontaminated (Berntssen et al., 2010b; 302 
Sprague et al., 2010). Since the algal biomass is produced under controlled conditions 303 
the potential for contamination from environmental pollutants and heavy metals is 304 
greatly reduced (Ratledge, 2005). The residual amounts of POPs measured in the 305 
algal feeds from the present study are therefore most likely contributable to other feed 306 
ingredients, most notably fish meal, since this along with fish oil is known to be a 307 
major POP contributor in fish feeds (Berntssen et al., 2010a; Jacobs et al., 2002). 308 
Equally, the utilization of rapeseed oil in both the precon and algal-based feeds may 309 
have resulted in the increase of another lipophilic POP not measured in this study. 310 
Polycyclic aromatic hydrocarbons (PAHs) were found to increase in fish flesh when 311 
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vegetable oils replaced fish oils, although organochlorine pesticides along with 312 
PCDD/Fs, PCBs and PBDEs decreased (Berntssen et al., 2010a).    313 
 314 
3.2. Growth and feed intake 315 
The replacement of fish oil with the algal biomass had no significant effect on 316 
the overall weight gain of fish (Table 3). However, fish fed the 11AM diet exhibited a 317 
minor but significantly lower growth rate than both fish oil treatments but not 5.5AM 318 
fed fish. This is in contrast to Carter et al. (2003) and Miller et al. (2007) who found 319 
no growth detriment when algal biomass or oil replaced fish oil in the diets of 320 
Atlantic salmon parr-smolts. In addition, the food conversion ratio (FCR) for both 321 
algal-fed treatments was significantly higher than NFO fed fish but similar to SFO. 322 
One possible explanation, particularly at the higher inclusion of algal meal, may be 323 
related to digestibility. In a similar study, Reitan, Erikson, Galloway, Berge and 324 
Kjørsvik (2012) replaced fish oil with other microalgae species (Nannochloropsis sp., 325 
Phaeodactylum tricornutum and Isochrysis galbana) in the diets of salmon and 326 
Atlantic cod, Gadus morhua. They found that inclusion levels up to 6% gave good 327 
digestibility whereas 12% microalgae inclusion resulted in a reduced digestibility, 328 
although appetite remained unchanged.  329 
No differences in the health status and/or immune function were recorded (data 330 
not presented), consistent with the results of several previous trials where partial or 331 
full replacement of fish oils were employed when using fish meal based diets (Bell et 332 
al., 2004; Bell et al., 2005).  333 
 334 
3.3. Flesh fatty acid and POP compositions 335 
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Flesh lipid levels of Atlantic salmon fed the enrichment diets significantly 336 
increased from initial levels of 6.7 to 10.1-11.2%, with no significant differences 337 
observed between the four dietary treatments (Table 4). Fatty acid compositions of 338 
the flesh accurately reflected that of the diet fed, in accordance with results normally 339 
found for salmon and other fish species (Sargent et al., 2002). The algal dietary 340 
treatments shared similar fatty acid profiles with elevated fillet flesh levels of 18:2n-6 341 
and 18:1n-9 compared to both fish oil treatments consistent with results where 342 
salmon have been fed diets based on plant oils due to the use of rapeseed oil in the 343 
diet (Bell et al., 2012; Miller et al., 2007). The major difference between the algal-fed 344 
treatments was a significantly higher level of DHA in the flesh of 11AM fish (8.9%) 345 
compared to 5.5AM fish (7.4%), arising from the difference in algal biomass 346 
inclusion. However, there was no overall increase in DHA in fish fed 5.5AM relative 347 
to initial levels (7.6%). Furthermore, percentage levels of DHA in the 11AM-fed fish 348 
were still significantly lower than for fish fed a fish oil based diet (10.4% SFO, 349 
11.7% NFO). This would suggest that an algal inclusion level greater than 11% is 350 
required to increase flesh DHA above basal levels and to establish similar levels to 351 
those found in fish oil based diets. In previous studies, Miller et al. (2007) and Carter 352 
et al. (2003) observed greater flesh DHA levels in salmon parr-smolts when 353 
Schizochytrium sp. replaced fish oil. However, caution should be applied when 354 
comparing results since the former authors utilised the richer oil extract as the sole oil 355 
source compared to a fish oil control whereas the latter authors elected to use 10% 356 
algal biomass and rapeseed, as in the present study, with a control diet consisting of a 357 
blend of vegetable and fish oils. While the latter control diet is more consistent with 358 
the formulation of commercial diets currently used by the industry, the present study 359 
sought to evaluate the dried algal biomass against a fish oil only diet to assess DHA 360 
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levels and is, to our knowledge, the first to trial Schizochytrium sp. as a potential fish 361 
oil replacement in grow-out feeds for Atlantic salmon. 362 
The most significant, but not unexpected, difference in flesh fatty acid content 363 
between dietary treatments is the lack of EPA in fish fed the algal diets (2.6 and 364 
2.9%, 11AM and 5.5AM respectively) compared to NFO (5.9%) and SFO (8.1%). 365 
This corresponds with results reported in earlier studies where a DHA-rich microalgal 366 
sp. replaced fish oil (Carter et al. 2003; Eryalçin et al., 2013; Ganuza et al., 2012; 367 
Miller et al., 2007). Moreover, EPA levels in the flesh of both algal treatments 368 
significantly decreased as compared to initial levels (4.9%), possibly a result of a 369 
dilution effect as flesh lipid increased or a depletion of this essential fatty acid. In 370 
general, n-3 LC-PUFA are important for the somatic growth of marine fish with DHA 371 
the most highly retained PUFA in a variety of species (Sargent et al., 2002). Ganuza 372 
et al. (2012) noted that growth, survival and disease resistance of sea bream larvae 373 
was unaffected when fish oil was substituted with Schizochytrium sp. but was altered 374 
when all dietary lipid (i.e. fish oil and fish meal) was replaced by algal biomass, a 375 
result of a dietary imbalance of fatty acids which was rectified by EPA 376 
supplementation. However, the dietary requirements of EPA and DHA in fish are 377 
more essential at early life stages (Sargent et al., 2002) and the inclusion of fish meal 378 
in the algal feeds would most likely have contained sufficient quantities of EPA for 379 
basic metabolic processes. Fish oil is still the main source of EPA, as the complex 380 
characteristics of EPA-producing algal species involve high-energy, high-costs and 381 
are time consuming (Ratledge, 2005). Nevertheless, since the trial was performed a 382 
Schizochytrium sp. algae with a minimum EPA and DHA content of no less than 10 383 
and 22%, respectively, has come on to the market (Gray, 2010), primarily targeting 384 
the feed/infant formulation sectors. More recently, Ruiz-Lopez, Haslam, Napier and 385 
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Sayanova (2014) have successfully produced an alternative transgenic plant source of 386 
n-3 LC-PUFA using an oilseed crop Camelina sativa to achieve levels of 12% EPA 387 
and 14% DHA, similar to levels found in fish oils which may have potential in 388 
aquafeeds (Betancor et al., 2015). 389 
The POP concentrations from the flesh of fish fed the experimental diets for 19-390 
weeks are presented in Table 5. Berntssen et al. (2010b) stress that feeding trials of 391 
short duration (e.g. 1-3 months) yield relatively lower levels of POPs compared to the 392 
typical time taken to farm salmon to harvest size, due to flesh POP accumulation over 393 
time. At the end of the present study significant differences in flesh POP levels 394 
between treatments were observed being in the order of NFO>SFO>11AM/5.5AM 395 
(0.803, 0.532, 0.247 and 0.263 pg.WHO-TEQ2005.g
-1
 ww PCDD/F + DL-PCBs 396 
respectively, and 1.233, 0.702, 0.268 and 0.267 ng.g
-1
 ww PBDEs respectively), 397 
reflecting the differences in dietary POP levels. Over the course of a full production 398 
cycle the fillet POP levels would further increase, although differences between 399 
dietary treatments would be expected to be maintained. Furthermore, the current costs 400 
for the algal biomass are similar to or even higher than those for fish meal and fish oil 401 
meaning that, at present, it is not practicable to feed the algal-based feeds over a full 402 
production cycle. Instead, it may be more economical to include algal diets as a 403 
finishing feed by first feeding a vegetable-based feed followed by a short-period of 404 
feeding the algal feeds, as performed in the present study. This would help alleviate 405 
costs as well as further reduce the POP levels, in contrast to fish oil finishing feeds 406 
(Bell et al., 2005; 2012). 407 
The lower levels of POPs, specifically PCDD/Fs and DL-PCBs, in the flesh of 408 
initial fish (0.156 pg.WHO-TEQ2005.g
-1
 ww) compared to algal-fed fish, despite the 409 
preconditioning diet containing higher POPs levels (0.267, 0.069 and 0.098 pgWHO-410 
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TEQ2005.g
-1
 ww, Precon, 11AM and 5.5AM, respectively), is most likely a result of 411 
differences in flesh lipid levels between initial (6.7%) and algal-fed fish (10.9 and 412 
11.2%, 11AM and 5.5AM, respectively) affecting the uptake of these lipophilic 413 
compounds. Thus, lipid normalized values were 2.33 (initial), 7.95 (NFO), 5.27 414 
(SFO), 2.27 (11AM) and 2.35 (5.5AM) pgWHO-TEQ2005.g
-1
 lw. 415 
 416 
3.4. Nutritional value from salmon consumption: risk-benefit 417 
One of the major selling points cited for consuming oily fish, such as salmon, is 418 
their unique source of n-3 LC PUFA, EPA and DHA, known to benefit human health 419 
(Calder & Yaqoob, 2009). Replacing fish oil with Schizochytrium sp. results in a 130 420 
g portion, as advised by the European Food Safety Authority (EFSA, 2005), 421 
providing 1.4 and 1.3 g of EPA+DHA, 11AM and 5.5AM respectively (Figure 1), 422 
equivalent to 40% (11AM) or 36% (5.5AM) of the suggested 3.5 g weekly intake of 423 
EPA+DHA recommended by the International Society for the Study of Fatty Acids 424 
and Lipids for optimal cardiac health in adults (ISSFAL, 2004). Nevertheless, this is 425 
still significantly less than for fish oil fed salmon, supplying 2.0 g (NFO) and 1.9 g 426 
(SFO) EPA+DHA or 57 and 53% of the recommended weekly intake respectively. 427 
This difference is attributable to differences in EPA levels, since the Schizochytrium 428 
sp. used was a DHA-rich only microalgae product and, as previously discussed, fish 429 
oil is still the main source of EPA. Despite this, algal-fed fish still remain a rich 430 
source of DHA when fed at the higher inclusion level, with no significant differences 431 
between absolute amounts of DHA in 11AM fish (1.1 ± 0.1 g.100g
-1
) compared to 432 
both NFO (1.2 ± 0.2 ) and SFO (1.1 ± 0.1 g.100g
-1
), despite differences in percentage 433 
terms. 434 
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Fish consumption also represents a major dietary exposure risk to humans 435 
through the accumulation of POPs. Accordingly, the European Scientific Committee 436 
on Food (SCF) has set a tolerable weekly intake (TWI) level of 14 pg.WHO-TEQ.kg
-
437 
1
 body wt for PCDD/Fs + DL-PCBs (SCF, 2001), equivalent to 980 pg.WHO-TEQ 438 
for an adult of 70 kg. Based on the same 130 g servings, NFO-fed fish contribute 439 
104.3 ± 8.1 pg.WHO-TEQ, significantly higher than SFO-fed fish (69.1 ± 3.0 440 
pg.WHO-TEQ) both of which are significantly higher than algal-fed fish (32.1 ± 2.4 441 
and 34.4 ± 3.1 pg.WHO-TEQ, 11AM and 5.5AM respectively). This represents just 442 
10.6% (NFO), 7.1% (SFO), 3.3% (11AM) and 3.5% (5.5AM) of the TWI for an adult 443 
of 70 kg. Food health authorities typically recommend consuming two portions of 444 
fish per week, one of which is oily (EFSA, 2005). From the present study, consuming 445 
two portions of either fish oil- or algal-fed fish would contribute 120-130 or 80-90% 446 
of the recommended EPA+DHA weekly intake and only 15-20 or 7% of the TWI for 447 
PCDD/Fs and DL-PCBs, respectively. These results indicate that previously 448 
identified high-risk groups such as young girls, women of child bearing age, and 449 
those pregnant and/or breast-feeding can safely consume more than two portions per 450 
week without exceeding their TWI, although this does not take into consideration 451 
POP intake from other dietary sources. 452 
At present, PBDE levels in foods are not limited by legislation although EFSA 453 
have issued an advisory TWI of 0.7 g.kg-1 body wt.week-1, equivalent to 49.0 g 454 
PBDE.week
-1
 for a 70 kg adult (EFSA, 2005). From the present study, a 130 g 455 
portion corresponds to 0.16 or 0.09 g PBDEs for the NFO and SFO treatments 456 
respectively and 0.03 g PBDEs for both algal treatments, all of which are less than 457 
1% of the advisory TWI for PBDEs.   458 
 459 
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4. Conclusion 460 
The replacement of fish oil with a DHA-rich Schizochytrium sp. microalgae 461 
significantly decreases both dietary and flesh fillet POP levels compared to fish oil 462 
based treatments. Moreover, flesh fillet DHA levels can be tailored to similar levels 463 
in fish oil fed fish when algal biomass is included at 11% of the diet. However, the 464 
absence of EPA in algal-based diets significantly impairs the overall nutritional value, 465 
in terms of g EPA+DHA per serving, to the final human consumer. Current and 466 
future developments in algal culture technology may provide a final affordable 467 
product of nutritional quality in terms of LC-PUFA content as an alternative to fish 468 
oil in aquafeeds.    469 
 470 
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Legend to Figure 605 
Figure 1. 606 
Risk-benefit association, in terms of PCDD/F+DL-PCBsWHO-TEQ2005 and EPA+DHA 607 
intake (mean ± SD), from 130 g consumption of Atlantic salmon fed one of four 608 
experimental diets. Dotted line represents the 980 pgWHO-TEQ TWI for an 609 
adult of 70 kg and the recommended 3.5 g EPA+DHA weekly intake for optimal 610 
cardiac health. Stacked bars represent contribution of DL-PCB and PCDD/Fs and 611 
EPA + DHA to respective total values. Initial data are presented for comparative 612 
purposes. 613 
  614 
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Figure 1. 615 
 616 
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Table 1. Ingredients, proximate composition (g.kg
-1
), energy (MJ.kg
-1
) and fatty acid 618 
content (% of total fatty acids) of the precondition and four experimental diets.    619 
 620 
 
Precon 
Experimental  
 NFO SFO 11%AM 5.5%AM 
Component (g.kg-1)      
  Fish meal 350 270 270 260 260 
  Vegetable protein concentrates 110 110 110 90 100 
  Oil seed meals 129 230 230 210 226 
  DDGS 40 - - - - 
  Starch sources 151 130 130 120 120 
  Premixes / micronutrients 7 5 5 5 5 
  Northern fish oil 32 270 - - - 
  Southern fish oil - - 270 - - 
  Rapeseed oil 185 - - 213 246 
  ABN AquaGrow® Gold - - - 110 55 
      
Analysed Composition (as is)      
  Lipid 252 300 303 318 313 
  Protein 393 342 349 336 347 
  Moisture 75 71 68 59 62 
  Ash 74 64 64 71 68 
  Gross energy (MJ.kg-1) 20.6 21.1 21.3 21.4 21.4 
      
Fatty acid (% of total)      
  14:0 1.7 5.3 6.4 2.6 1.7 
  16:0 8.4 14.1 16.0 10.3 8.2 
  18:0 2.2 2.6 2.8 2.0 1.9 
  Total saturates1 13.2 22.7 25.9 15.9 12.7 
      
  16:1n-7 2.1 4.8 6.8 0.7 1.1 
  18:1n-9 45.5 13.2 11.6 43.4 45.8 
  18:1n-7 3.5 2.6 2.8 2.5 3.1 
  20:1n-9 1.4 7.6 5.4 1.2 1.5 
  22:1n-11 0.5 12.1 8.2 0.1 0.5 
  Total monoenes2 53.5 43.3 36.8 48.6 52.9 
      
  18:2n-6 17.9 5.8 5.2 16.2 17.5 
  20:2n-6 0.1 0.3 0.2 0.1 0.1 
  20:4n-6 0.2 0.6 0.7 0.4 0.3 
  22:5n-6 0.1 0.2 0.2 2.5 1.3 
  Total n-6 PUFA3 18.2 7.2 6.6 19.2 19.1 
      
  18:3n-3 7.0 1.3 1.0 6.1 6.9 
  18:4n-3 0.5 3.1 2.9 0.2 0.3 
  20:5n-3 3.6 8.0 12.3 1.2 2.0 
  22:5n-3 0.4 1.7 1.6 0.2 0.3 
  22:6n-3 2.3 10.2 8.4 8.1 5.3 
  Total n-3 PUFA4 13.9 25.4 27.0 16.0 14.8 
      
  Total PUFA5 33.3 34.0 37.3 35.5 34.4 
      
  n-3:n-6 0.8 3.5 4.1 0.8 0.8 
Values are presented as means based upon duplicate analyses 621 
1includes 15:0, 20:0, 22:0, 24:0 622 
2includes 16:1n-9, 20:1n-11, 20:1n-7, 22:1n-9, 24:1 623 
3includes 18:3n-6, 20:2n-6, 20:3n-6, 22:4n-6 624 
4includes 20:3n-3, 20:4n-3  625 
5includes 16:2, 16:3, 16:4 626 
627 
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Table 2. Concentrations of PCDD/Fs, DL-PCBs (pg.g
-1
 ww, upperbound WHO-628 
TEQ2005) and PBDEs (ng.g
-1
 ww) in the precondition and four experimental diets fed 629 
to Atlantic salmon. WHO-TEQ1998 are presented for comparative purposes. 630 
 
Precon 
Experimental  
 NFO SFO 11%AM 5.5%AM 
PCDD      
  2378-TCDD 0.012 0.052 0.016 0.010 0.010 
  12378-PeCDD 0.059 0.113 0.051 0.010 0.010 
  123478-HxCDD 0.0015 0.0019 0.0010 0.0010 0.0010 
  123678-HxCDD 0.002 0.013 0.002 0.003 0.003 
  123789-HxCDD 0.0010 0.0011 0.0010 0.0010 0.0010 
  1234678-HpCDD 0.0003 0.0015 0.0004 0.0007 0.0007 
  OCDD <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
  PCDD 0.076 0.183 0.071 0.026 0.026 
      
PCDF      
  2378-TCDF 0.0053 0.1463 0.0470 0.0042 0.0071 
  12378-PeCDF 0.0005 0.0052 0.0040 0.0003 0.0003 
  23478-PeCDF 0.012 0.174 0.110 0.006 0.016 
  123478-HxCDF 0.001 0.001 0.002 0.001 0.001 
  123678-HxCDF 0.0010 0.0046 0.0032 0.0010 0.0010 
  234678-HxCDF 0.0024 0.0046 0.0013 0.0010 0.0010 
  123789-HxCDF 0.001 0.001 0.001 0.001 0.001 
  1234678-HpCDF 0.0008 0.0020 0.0009 0.0004 0.0006 
  1234789-HpCDF <0.0001 0.0003 0.0001 0.0004 0.0002 
  OCDF <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
  PCDF 0.024 0.339 0.169 0.015 0.028 
      
DL-PCBs      
Non-ortho PCBs      
  PCB 77 0.0013 0.0048 0.0040 0.0004 0.0005 
  PCB 81 0.0001 0.0006 0.0007 0.0001 <0.0001 
  PCB 126 0.132 1.156 0.643 0.024 0.038 
  PCB 169 0.026 0.058 0.038 0.001 0.002 
  non-ortho PCBs 0.159 1.219 0.686 0.026 0.041 
      
Mono-ortho PCBs      
  PCB 105 0.0022 0.0208 0.0111 0.0005 0.0009 
  PCB 114 <0.0001 0.0009 0.0006 <0.0001 <0.0001 
  PCB 118 0.005 0.051 0.030 0.001 0.002 
  PCB 123 0.0003 0.0010 0.0007 <0.0001 <0.0001 
  PCB 156 0.0003 0.0041 0.0020 <0.0001 0.0001 
  PCB 157 <0.0001 0.0017 0.0008 <0.0001 <0.0001 
  PCB 167 0.0002 0.0023 0.0011 <0.0001 <0.0001 
  PCB 189 <0.0001 0.0007 0.0003 <0.0001 <0.0001 
  mono-ortho PCBs 0.008 0.083 0.047 0.002 0.003 
      
  PCDD/Fs2005 0.100 0.522 0.240 0.041 0.054 
  DL-PCBs2005 0.167 1.302 0.733 0.028 0.044 
  PCDD/Fs+DL-PCBs2005
1 0.267 1.824 0.973 0.069 0.098 
      
  PCDD/Fs+DL-PCBs1998
2 0.285 2.180 1.170 0.080 0.120 
      
Polybrominated diphenyl ethers 
  BDE28 0.009 0.053 0.028 0.008 0.008 
  BDE47 0.141 1.126 0.526 0.006 0.006 
  BDE49 0.037 0.396 0.183 0.006 0.006 
  BDE66 nd 0.052 0.022 0.006 0.006 
  BDE99 0.040 0.214 0.086 0.093 0.015 
  BDE100 0.032 0.364 0.165 0.012 0.006 
  BDE 153 0.006 0.033 0.012 0.011 0.006 
  BDE 154 0.008 0.157 0.064 0.012 0.006 
  BDE 183 nd nd nd nd nd 
9 PBDEs 0.273 2.395 1.086 0.154 0.059 
Values are presented as means based upon duplicate analyses 631 
 30 
nd – not detected 632 
1TEF2005, Van den Berg et al. (2006) 633 
2TEF1998, Van den Berg et al. (1998) 634 
  635 
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Table 3. Growth performance of Atlantic salmon fed experimental diets for 19 636 
weeks. Means (%RSD) bearing identical superscripts are not significantly different 637 
(P>0.05). 638 
 NFO SFO 11%AM 5.5%AM 
Initial mass (g) 1544 (1.0) 1527 (1.1) 1543 (1.2) 1522 (2.9) 
Final mass (g) 3245 (2.0) 3220 (2.7) 3030 (4.9) 3170 (3.7) 
Weight gain (g) 1701 (3.4) 1692 (4.2) 1487 (8.9) 1648 (4.7) 
SGR (% bw.day-1) 0.59 (2.0)a 0.59 (2.6)a 0.53 (5.7)b 0.58 (1.7)ab 
Total feed consumption (kg) 251.2 (2.1) 258.7 (2.5) 254.5 (1.3) 248.9 (0.8) 
FCR 1.28 (3.9)a 1.35 (1.9)ab 1.42 (1.9)b 1.40 (2.5)b 
 639 
640 
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Table 4. Lipid (%) and fatty acid composition (% of total lipid) from flesh of initial 641 
and Atlantic salmon fed one of four experimental enrichment diets. Means bearing 642 
identical superscripts within same row are not significantly different (P>0.05).  643 
 
Initial 
Experimental  
 NFO SFO 11%AM 5.5%AM 
n 4 6 6 6 6 
Lipid (%) 6.7 (9.9)
a 10.1 (9.3)b 10.1 (11.7)b 10.9 (15.5)b 11.2 (7.1)b 
      
Fatty acid      
  14:0 3.0 (4.7)a 3.8 (6.6)b 4.3 (6.8)c 2.3 (7.8)d 2.3 (3.7)d 
  16:0 13.2 (3.1)a 13.5 (1.2)a 14.6 (3.8)b 10.7 (4.4)c 10.8 (3.5)c 
  18:0 3.4 (3.1)a 3.1 (1.1)b 3.3 (3.5)a 2.7 (4.3)c 2.8 (4.5)c 
  20:0 0.3 (9.4)a 0.2 (6.8)a 0.2 (9.8)a 0.3 (1.9)a 0.3 (4.4)a 
  Total saturates1 20.2 (3.2)a 20.9 (2.0)a 22.7 (4.1)b 16.4 (5.2)c 16.5 (3.2)c 
      
  16:1n-7 4.0 (3.2)a 4.3 (2.9)b 5.6 (2.5)c 2.0 (7.1)d 2.4 (3.2)e 
  18:1n-9 32.8 (1.9)a 20.9 (2.7)b 19.7 (3.2)c 38.0 (1.0)d 38.1 (1.3)d 
  18:1n-7 3.4 (4.2)a 3.1 (3.0)bc 3.2 (1.5)abc 3.0 (1.2)c 3.3 (6.2)ab 
  20:1n-9 2.7 (4.8)a 6.2 (2.8)b 4.8 (1.9)c 2.6 (4.1)a 3.1 (4.5)d 
  22:1n-11 0.9 (7.6)a 6.3 (5.3)b 4.5 (4.2)c 0.6 (18.8)a 1.0 (12.3)d 
  22:1n-9 0.4 (11.1)ad 0.7 (8.9)b 0.5 (4.8)c 0.4 (7.1)d 0.4 (9.3)d 
  24:1n-9 0.4 (3.4)ad 0.9 (6.5)b 0.7 (13.6)c 0.4 (11.8)a 0.5 (9.8)d 
  Total monoenes2 45.0 (2.0)a 42.9 (1.3)b 39.7 (0.9)c 47.3 (1.0)d 49.1 (1.1)e 
      
  18:2n-6 11.4 (2.0)a 7.7 (2.8)b 7.2 (4.1)c 13.4 (2.5)d 13.3 (1.8)d 
  20:2n-6 0.8 (2.1)a 0.6 (3.8)b 0.5 (3.7)c 1.0 (4.1)d 1.0 (4.0)d 
  20:4n-6 0.5 (5.9)ad 0.6 (3.1)ac 0.6 (6.2)c 0.6 (4.6)ac 0.5 (4.5)d 
  22:5n-6 0.1 (18.2)a 0.2 (6.5)b 0.2 (5.6)b 1.5 (5.5)c 0.9 (1.4)d 
  Total n-6 PUFA3 13.2 (1.6)a 9.6 (2.6)b 9.1 (3.8)b 16.7 (2.6)c 16.0 (1.5)d 
      
  18:3n-3 3.8 (4.0)a 2.1 (5.3)b 1.8 (7.7)c 4.6 (3.8)d 4.5 (2.1)d 
  18:4n-3 0.8 (3.4)a 1.6 (3.1)b 1.6 (2.3)b 0.5 (5.0)c 0.5 (7.0)c 
  20:4n-3 0.8 (6.7)a 1.5 (2.2)b 1.3 (1.0)c 0.6 (3.2)d 0.6 (4.8)d 
  20:5n-3 4.9 (6.7)a 5.9 (3.3)b 8.1 (3.1)c 2.6 (6.6)d 2.9 (6.7)d 
  22:5n-3 2.1 (4.4)a 2.8 (1.8)b 3.3 (1.9)c 1.3 (4.5)d 1.4 (6.5)d 
  22:6n-3 7.6 (8.5)a 11.7 (2.7)b 10.4 (3.1)c 8.9 (6.0)d 7.4 (3.8)a 
  Total n-3 PUFA4 20.4 (6.0)a 25.7 (1.9)b 26.7 (2.4)b 18.9 (4.4)c 17.7 (3.4)c 
      
  Total PUFA5 34.8 (3.8)ab 36.2 (1.4)ac 37.6 (2.5)c 36.2 (3.4)ac 34.4 (2.4)b 
      
  n-3:n-6 1.5 (5.7)a 2.7 (0.1)b 2.9 (2.8)c 1.1 (0.0)d 1.1 (0.0)d 
1includes 15:0, 22:0, 24:0 644 
2includes 16:1n-9, 20:1n-11, 20:1n-7 645 
3includes 18:3n-6, 20:3n-6, 22:4n-6 646 
4includes 20:3n-3 647 
5includes 16:2, 16:3, 16:4 648 
649 
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Table 5. Concentrations of PCDD/Fs, DL-PCBs (pg.g
-1
 ww, upperbound WHO-650 
TEQ2005) and PBDEs (ng.g
-1
 ww) in fillet flesh of initial and experimental fed 651 
Atlantic salmon. mean values (%RSD) bearing identical superscript lettering within 652 
same row are not statistically different (P>0.05). WHO-TEQ1998 are presented for 653 
comparative purposes. 654 
 
Initial 
Experimental  
 NFO SFO 11%AM 5.5%AM 
n 2 3 3 3 3 
PCDD      
  2378-TCDD 0.010 (0) 0.017 (19) 0.015 (26) 0.010 (0) 0.010 (0) 
  12378-PeCDD 0.010 (0) 0.032 (27) 0.029 (36) 0.011 (16) 0.012 (29) 
  123478-HxCDD 0.0015 (44) 0.0010 (0) 0.0010 (0) 0.0010 (0) 0.0010 (0) 
  123678-HxCDD 0.001 (0) 0.0013 (28) 0.001 (0) 0.0011 (16) 0.0013 (4) 
  123789-HxCDD 0.0010 (0) 0.0010 (0) 0.001 (0) 0.001 (0) 0.001 (0) 
  1234678-HpCDD 0.0005 (24) 0.0001 (17) 0.0001 (23) 0.0002 (54) 0.0001 (17) 
  OCDD <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
PCDD 0.024 (3)
a 0.052 (22)b 0.047 (28)b 0.024 (8)a 0.025 (13)a 
      
PCDF      
  2378-TCDF 0.0015 (15) 0.049 (29) 0.025 (44) 0.015 (3) 0.018 (3) 
  12378-PeCDF 0.0011 (63) 0.0017 (14) 0.0009 (11) 0.0004 (44) 0.0006 (14) 
  23478-PeCDF 0.026 (29) 0.054 (10) 0.034 (21) 0.012 (22) 0.016 (12) 
  123478-HxCDF 0.001 (0) 0.001 (0) 0.001 (0) 0.001 (0) 0.001 (0) 
  123678-HxCDF 0.0012 (24) 0.0010 (0) 0.0010 (0) 0.0010 (0) 0.0011 (20) 
  234678-HxCDF 0.0010 0.0011 (16) 0.0011 (9) 0.0010 (0) 0.0010 (11) 
  123789-HxCDF 0.001 (0) 0.001 (0) 0.001 (0) 0.001 (0) 0.0012 (29) 
  1234678-HpCDF 0.0001 0.0002 (33) 0.0003 (13) 0.0007 (68) 0.0001 (9) 
  1234789-HpCDF 0.0002 (42) 0.0001 (0) 0.0001 (0) 0.0001 (0) 0.0001 (0) 
  OCDF <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
PCDF 0.033 (25)
a 0.109 (8)b 0.064 (28)c 0.032 (7)a 0.039 (7)ac 
      
DL-PCBs      
Non-ortho PCBs      
  PCB 77 0.0007 (17) 0.0020 (4) 0.0017 (9) 0.0022 (76) 0.0008 (10) 
  PCB 81 <0.0001 0.0002 (12) 0.0003 (24) 0.0003 (46) <0.0001 
  PCB 126 0.080 (37) 0.576 (9) 0.379 (5) 0.169 (7) 0.181 (9) 
  PCB 169 0.003 (25) 0.023 (3) 0.013 (27) 0.005 (31) 0.006 (18) 
non-ortho PCBs 0.084 (36)
a 0.601 (8)b 0.394 (5)c 0.177 (8)d 0.188 (9)d 
      
Mono-ortho PCBs      
  PCB 105 0.0034 (6) 0.0101(4) 0.0065 (11) 0.0035 (32) 0.0027 (13) 
  PCB 114 0.0002 (25) 0.0005 (3) 0.0003 (11) 0.0002 (47) 0.0001 (17) 
  PCB 118 0.0086 (10) 0.025 (3) 0.017 (7) 0.009 (28) 0.007 (12) 
  PCB 123 0.0004 (15) 0.0003 (14) 0.0002 (40) 0.0002 (76) <0.0001 
  PCB 156 0.0011 (6) 0.0022 (9) 0.0015 (13) 0.0008 (8) 0.0007 (10) 
  PCB 157 0.0003 (7) 0.0009 (13) 0.0005 (8) 0.0003 (1) 0.0003 (20) 
  PCB 167 0.0005 (12) 0.0013 (10) 0.0008 (8) 0.0004 (9) 0.0004 (11) 
  PCB 189 0.0001 (2) 0.0004 (4) 0.0002 (9) <0.0001 <0.0001 
mono-ortho PCBs 0.015 (8)
a 0.041 (4)b 0.027 (8)c 0.014 (28)a 0.011 (11)a 
      
PCDD/Fs2005 0.057 (16)
a 0.161(8)b 0.111 (13)c 0.056 (4)ad 0.064 (8)d 
DL-PCBs2005 0.099 (32)
a 0.642 (8)b 0.421 (5)c 0.191 (10)a 0.199 (9)a 
PCDD/Fs+DL-PCBs2005
1 0.156 (14)
a 0.803(8)b 0.532 (4)c 0.247 (8)d 0.263 (9)d 
      
PCDD/Fs+DL-PCBs1998
2 0.227 (9)
a 0.963 (7)b 0.638 (4)c 0.301 (9)d 0.312 (9)d 
      
Polybrominated diphenyl ethers 
  BDE28 0.016 (14) 0.036 (5) 0.023 (5) 0.009 (11) 0.007 (8) 
  BDE47 0.250 (8) 0.610 (6) 0.365 (7) 0.141 (3) 0.144 (6) 
  BDE49 0.059 (10) 0.173 (5) 0.100 (9) 0.034 (5) 0.033 (3) 
  BDE66 0.010 (7) 0.030 (5) 0.015 (12) 0.007 (0) 0.006 (0) 
  BDE99 0.041 (14) 0.113 (5) 0.057 (11) 0.029 (7) 0.027 (4) 
  BDE100 0.047 (8) 0.176 (4) 0.090 (7) 0.027 (8) 0.028 (7) 
  BDE 153 0.008 (28) 0.017 (7) 0.009 (6) 0.006 (0) 0.007 (0) 
 34 
  BDE 154 0.025 (14) 0.078 (2) 0.043 (7) 0.015 (4) 0.015 (4) 
  BDE 183 nd nd nd nd nd 
9 PBDEs 0.456 (10)
a 1.233 (5)b 0.702 (8)c 0.268 (3)d 0.267 (4)d 
nd - not detected 655 
1TEF2005, Van den Berg et al. (2006) 656 
2TEF1998, Van den Berg et al. (1998) 657 
 658 
